World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Tarsus Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    10,892
    Market Cap (Jan-05-2024)
    0.662 Billion USD
    World Rank (Jul-30-2023)
    11,446
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    14,096
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    13,834
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    26 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -62 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
    Company Website
    TARSUS PHARMACEUTICALS, INC.

  2. Calliditas Therapeutics AB (publ)

    World Rank (Jan-05-2024)
    10,901
    Market Cap (Jan-05-2024)
    0.661 Billion USD
    World Rank (Jul-30-2023)
    12,959
    Market Cap (Jul-30-2023)
    0.484 Billion USD
    World Rank (Dec-25-2022)
    12,781
    Market Cap (Dec-25-2022)
    0.472 Billion USD
    World Rank (Jan-07-2022)
    12,195
    Market Cap (Jan-07-2022)
    0.61 Billion USD
    Annual Revenue in USD
    22 Million USD
    Annual Net Income in USD
    -47 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Sweden
    Yahoo @ Stockholm
    Company Website
    CALLIDITAS THERAPEUTICS AB (PUBL)

  3. Centessa Pharmaceuticals PLC

    World Rank (Jan-05-2024)
    10,928
    Market Cap (Jan-05-2024)
    0.657 Billion USD
    World Rank (Jul-30-2023)
    10,198
    Market Cap (Jul-30-2023)
    0.762 Billion USD
    World Rank (Dec-25-2022)
    15,498
    Market Cap (Dec-25-2022)
    0.310 Billion USD
    World Rank (Jan-07-2022)
    10,634
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Headquarters Country
    UK
    Yahoo @ Nasdaq
    Company Website
    CENTESSA PHARMACEUTICALS PLC

  4. Edgewise Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,027
    Market Cap (Jan-05-2024)
    0.646 Billion USD
    World Rank (Jul-30-2023)
    13,494
    Market Cap (Jul-30-2023)
    0.444 Billion USD
    World Rank (Dec-25-2022)
    11,911
    Market Cap (Dec-25-2022)
    0.540 Billion USD
    World Rank (Jan-07-2022)
    10,206
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -42 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    EDGEWISE THERAPEUTICS, INC. is a biotechnology sector company that creates medicines for rare muscle disorders. Headquarters is in USA.
    Company Website
    EDGEWISE THERAPEUTICS, INC.

  5. Urovant Sciences

    World Rank (Jan-05-2024)
    11,036
    World Rank (Jul-30-2023)
    11,036
    World Rank (Dec-25-2022)
    11,036
    World Rank (Jan-07-2022)
    11,036
    Headquarters Country
    USA
    Company Profile
    Urovant Sciences is a Biopharmaceutical company focused on developing and commercializing innovative therapies for a range of urologic conditions. The company estimated annual revenue is currently 39.2 million USD per year. The headquarters is in USA.
    Company Website
    UROVANT SCIENCES

  6. Shenzhen Bioeasy Biotechnology Co. Ltd

    World Rank (Jan-05-2024)
    11,045
    Market Cap (Jan-05-2024)
    0.645 Billion USD
    World Rank (Jul-30-2023)
    10,467
    Market Cap (Jul-30-2023)
    0.727 Billion USD
    World Rank (Dec-25-2022)
    7,944
    Market Cap (Dec-25-2022)
    1.095 Billion USD
    World Rank (Jan-07-2022)
    6,645
    Market Cap (Jan-07-2022)
    1.83 Billion USD
    Headquarters Country
    China
    Company Website
    SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.

  7. Wave Life Sciences

    World Rank (Jan-05-2024)
    11,188
    Market Cap (Jan-05-2024)
    0.631 Billion USD
    World Rank (Jul-30-2023)
    14,083
    Market Cap (Jul-30-2023)
    0.403 Billion USD
    World Rank (Dec-25-2022)
    11,621
    Market Cap (Dec-25-2022)
    0.566 Billion USD
    World Rank (Jan-07-2022)
    19,803
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Singapore
    Stock Category
    Singapore ADRs
    Yahoo @ Nasdaq
    Company Website
    WAVE LIFE SCIENCES LTD.

  8. Altimmune Inc.

    World Rank (Jan-05-2024)
    11,224
    Market Cap (Jan-05-2024)
    0.628 Billion USD
    World Rank (Jul-30-2023)
    19,229
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    9,786
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    15,840
    Market Cap (Jan-07-2022)
    0.34 Billion USD
    Headquarters Country
    USA
    Company Profile
    Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases and intranasal vaccines. The company annual revenue is 8.1 million USD and total assets are 245 million USD as on 2020. The headquarters is in USA.
    Company Website
    ALTIMMUNE, INC.

  9. Altimmune

    World Rank (Jan-05-2024)
    11,225
    Market Cap (Jan-05-2024)
    0.628 Billion USD
    World Rank (Jul-30-2023)
    19,230
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    9,933
    Market Cap (Dec-25-2022)
    0.754 Billion USD
    World Rank (Jan-07-2022)
    16,056
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Net Income in USD
    -49 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    ALTIMMUNE

  10. MacroGenics Inc.

    World Rank (Jan-05-2024)
    11,264
    Market Cap (Jan-05-2024)
    0.623 Billion USD
    World Rank (Jul-30-2023)
    16,045
    Market Cap (Jul-30-2023)
    0.289 Billion USD
    World Rank (Dec-25-2022)
    14,480
    Market Cap (Dec-25-2022)
    0.365 Billion USD
    World Rank (Jan-07-2022)
    9,924
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -202 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    MacroGenics is a Clinical Stage Biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody based therapeutics for the treatment of cancer. The company annual revenue is 64 million USD and  307 employees as on 2019. The headquarters is in USA.
    Company Website
    MACROGENICS

Share